In the lead-up to European regulators’ December decision on Aduhelm’s approval for use in the European Union, an expert panel declined to give the…
New clinical trials on memory loss interventions is currently enrolling participants with key Alzhemier’s biomarkers as young as 55 and 60 years old. Tau…
Can too much coffee shrink your brain? Bad news arrived recently for the constantly caffeinated: Researchers recently found evidence that drinking more than six…
The FDA expresses early confidence in Altoida’s investigational tech gadget, designed to predict whether someone will develop Alzheimer’s in the next year. Studies so…
Will Medicare cover Alzheimer’s drugs like Aduhelm? That decision-making process is underway. This week, the U.S. government embarked on the formal review process to…
This week, on the heels of Aduhelm’s FDA approval, the agency granted breakthrough status to two more prospective new Alzheimer’s treatments, Eli Lilly &…
After much controversy, more resignations in protest against the FDA accelerated approval of Biogen’s Alzheimer’s drug Aduhelm (aducanumab). In a bold act of protest…